Roche has entered into a five year collaboration agreement with a manufacturer of diagnostic products, Hycor Biomedical.
Under the agreement, Roche will distribute Hycor’s KOVA urinalysis plastics and controls products with its urinalysis tests and platforms.
KOVA urinalysis controls include specially engineered Glasstic slides and sample tubes which are used to validate the performance of urine chemistry test strips and readers and to help focus microscopic sediment analysis.
Roche professional diagnostics head Colin Brown said, "Concurrent with our global leading position in in-vitro diagnostics, the expanded agreement with HYCOR emphasizes our commitment of bringing industry expertise in providing high-quality urinalysis products to health professionals at hospital laboratories."
Hycor president and CEO Dick Aderman said, "This agreement allows us to expand our presence into an additional 85 markets, further underscoring the value it brings to the healthcare professionals and patients it serves."